BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 36599082)

  • 1. GALR2 and Y1R agonists intranasal infusion enhanced adult ventral hippocampal neurogenesis and antidepressant-like effects involving BDNF actions.
    Alvarez-Contino JE; Díaz-Sánchez E; Mirchandani-Duque M; Sánchez-Pérez JA; Barbancho MA; López-Salas A; García-Casares N; Fuxe K; Borroto-Escuela DO; Narváez M
    J Cell Physiol; 2023 Feb; 238(2):459-474. PubMed ID: 36599082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term enhancements in antidepressant efficacy and neurogenesis: Effects of intranasal co-administration of neuropeptide Y 1 receptor (NPY1R) and galanin receptor 2 (GALR2) agonists in the ventral hippocampus.
    Beltran-Casanueva R; Hernández-García A; Serrano-Castro PJ; Sánchez-Pérez JA; Barbancho-Fernández MA; García-Casares N; Fuxe K; Borroto-Escuela DO; Narváez M
    FASEB J; 2024 Apr; 38(7):e23595. PubMed ID: 38572811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galanin and neuropeptide Y interactions elicit antidepressant activity linked to neuronal precursor cells of the dentate gyrus in the ventral hippocampus.
    Borroto-Escuela DO; Pita-Rodriguez M; Fores-Pons R; Barbancho MA; Fuxe K; Narváez M
    J Cell Physiol; 2021 May; 236(5):3565-3578. PubMed ID: 33044017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased medial prefrontal cortex activity related to impaired novel object preference task performance following GALR2 and Y1R agonists intranasal infusion.
    Díaz-Sánchez E; López-Salas A; Mirchandani-Duque M; Alvarez-Contino JE; Sánchez-Pérez JA; Fuxe K; Borroto-Escuela DO; García-Casares N; Narváez M
    Biomed Pharmacother; 2023 May; 161():114433. PubMed ID: 36848750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal Delivery of Galanin 2 and Neuropeptide Y1 Agonists Enhanced Spatial Memory Performance and Neuronal Precursor Cells Proliferation in the Dorsal Hippocampus in Rats.
    Borroto-Escuela DO; Fores R; Pita M; Barbancho MA; Zamorano-Gonzalez P; Casares NG; Fuxe K; Narváez M
    Front Pharmacol; 2022; 13():820210. PubMed ID: 35250569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galanin and Neuropeptide Y Interaction Enhances Proliferation of Granule Precursor Cells and Expression of Neuroprotective Factors in the Rat Hippocampus with Consequent Augmented Spatial Memory.
    Mirchandani-Duque M; Barbancho MA; López-Salas A; Alvarez-Contino JE; García-Casares N; Fuxe K; Borroto-Escuela DO; Narváez M
    Biomedicines; 2022 Jun; 10(6):. PubMed ID: 35740319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced neuronal survival and BDNF elevation via long-term co-activation of galanin 2 (GALR2) and neuropeptide Y1 receptors (NPY1R): potential therapeutic targets for major depressive disorder.
    Borroto-Escuela D; Serrano-Castro P; Sánchez-Pérez JA; Barbancho-Fernández MA; Fuxe K; Narváez M
    Expert Opin Ther Targets; 2024 Apr; 28(4):295-308. PubMed ID: 38622072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentiation of antidepressant effects: NPY1R agonist and ketamine synergy enhances TrkB signaling and neurogenesis in the ventral hippocampus.
    Arrabal-Gómez C; Serrano-Castro P; Sánchez-Pérez JA; Garcia-Casares N; Fuxe K; Borroto-Escuela D; Narváez M
    Expert Opin Ther Targets; 2024 Apr; 28(4):309-322. PubMed ID: 38626283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galanin receptor 2-neuropeptide Y Y1 receptor interactions in the dentate gyrus are related with antidepressant-like effects.
    Narváez M; Borroto-Escuela DO; Millón C; Gago B; Flores-Burgess A; Santín L; Fuxe K; Narváez JA; Díaz-Cabiale Z
    Brain Struct Funct; 2016 Nov; 221(8):4129-4139. PubMed ID: 26666529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of neurogenesis and cognition through intranasal co-delivery of galanin receptor 2 (GALR2) and neuropeptide Y receptor 1 (NPY1R) agonists: a potential pharmacological strategy for cognitive dysfunctions.
    Sánchez-Varo R; López-Salas A; Beltran-Casanueva R; Díaz-Sánchez E; Alvarez-Contino JE; Barbancho-Fernández MA; Serrano-Castro P; Fuxe K; Borroto-Escuela DO; García-Casares N; Narváez M
    Behav Brain Funct; 2024 Mar; 20(1):6. PubMed ID: 38549164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The neuropeptide Y Y1 receptor subtype is necessary for the anxiolytic-like effects of neuropeptide Y, but not the antidepressant-like effects of fluoxetine, in mice.
    Karlsson RM; Choe JS; Cameron HA; Thorsell A; Crawley JN; Holmes A; Heilig M
    Psychopharmacology (Berl); 2008 Jan; 195(4):547-57. PubMed ID: 17891380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galanin (1-15) enhances the antidepressant effects of the 5-HT1A receptor agonist 8-OH-DPAT: involvement of the raphe-hippocampal 5-HT neuron system.
    Millón C; Flores-Burgess A; Narváez M; Borroto-Escuela DO; Santín L; Gago B; Narváez JA; Fuxe K; Díaz-Cabiale Z
    Brain Struct Funct; 2016 Dec; 221(9):4491-4504. PubMed ID: 26792005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropeptide S in the basolateral amygdala mediates an adaptive behavioral stress response in a rat model of posttraumatic stress disorder by increasing the expression of BDNF and the neuropeptide YY1 receptor.
    Cohen H; Vainer E; Zeev K; Zohar J; Mathé AA
    Eur Neuropsychopharmacol; 2018 Jan; 28(1):159-170. PubMed ID: 29157796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain-derived neurotrophic factor, phosphorylated cyclic AMP response element binding protein and neuropeptide Y decline as early as middle age in the dentate gyrus and CA1 and CA3 subfields of the hippocampus.
    Hattiangady B; Rao MS; Shetty GA; Shetty AK
    Exp Neurol; 2005 Oct; 195(2):353-71. PubMed ID: 16002067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancing Cognitive Functions and Neuronal Growth through NPY1R Agonist and Ketamine Co-Administration: Evidence for NPY1R-TrkB Heteroreceptor Complexes in Rats.
    Arrabal-Gómez C; Beltran-Casanueva R; Hernández-García A; Bayolo-Guanche JV; Barbancho-Fernández MA; Serrano-Castro PJ; Narváez M
    Cells; 2024 Apr; 13(8):. PubMed ID: 38667284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preferential activation by galanin 1-15 fragment of the GalR1 protomer of a GalR1-GalR2 heteroreceptor complex.
    Borroto-Escuela DO; Narvaez M; Di Palma M; Calvo F; Rodriguez D; Millon C; Carlsson J; Agnati LF; Garriga P; Díaz-Cabiale Z; Fuxe K
    Biochem Biophys Res Commun; 2014 Sep; 452(3):347-53. PubMed ID: 25152404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Integrative Mechanism in Anxiolytic Behavior Induced by Galanin 2/Neuropeptide Y Y1 Receptor Interactions on Medial Paracapsular Intercalated Amygdala in Rats.
    Narváez M; Borroto-Escuela DO; Santín L; Millón C; Gago B; Flores-Burgess A; Barbancho MA; Pérez de la Mora M; Narváez J; Díaz-Cabiale Z; Fuxe K
    Front Cell Neurosci; 2018; 12():119. PubMed ID: 29765307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GalR2/3 mediates proliferative and trophic effects of galanin on postnatal hippocampal precursors.
    Abbosh C; Lawkowski A; Zaben M; Gray W
    J Neurochem; 2011 May; 117(3):425-36. PubMed ID: 21281311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropeptide Y receptor 1 and galanin receptor 2 (NPY1R-GALR2) interactions in the dentate gyrus and their relevance for neurogenesis and cognition.
    Beltran-Casanueva R; Hernández-García A; de Amo García P; Blanco-Reina E; Serrano-Castro P; García-Casares N; Fuxe K; Borroto-Escuela DO; Narváez M
    Front Cell Neurosci; 2024; 18():1323986. PubMed ID: 38425430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virus-Mediated Overexpression of ETS-1 in the Ventral Hippocampus Counteracts Depression-Like Behaviors in Rats.
    Luo H; Liu Z; Liu B; Li H; Yang Y; Xu ZD
    Neurosci Bull; 2019 Dec; 35(6):1035-1044. PubMed ID: 31327148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.